Thread: New Data Showed LIVALO® (pitavastatin) Met Primary Endpoint of LDL-C Reduction ... - DigitalJournal.com (press release)
View Single Post
  #1  
Unread 05-31-2012, 05:03 PM
nmrlearner's Avatar
nmrlearner nmrlearner is offline
Senior Member
  
Join Date: Jan 2005
Posts: 23,173
Points: 193,617, Level: 100
Points: 193,617, Level: 100 Points: 193,617, Level: 100 Points: 193,617, Level: 100
Level up: 0%, 0 Points needed
Level up: 0% Level up: 0% Level up: 0%
Activity: 50.7%
Activity: 50.7% Activity: 50.7% Activity: 50.7%
Last Achievements
Award-Showcase
NMR Credits: 0
NMR Points: 0
Downloads: 0
Uploads: 0
Default New Data Showed LIVALO® (pitavastatin) Met Primary Endpoint of LDL-C Reduction ... - DigitalJournal.com (press release)


New Data Showed LIVALO® (pitavastatin) Met Primary Endpoint of LDL-C Reduction ...
DigitalJournal.com (press release)
[1] In addition, the effect of LIVALO and pravastatin on individual lipoprotein particles was evaluated as a pre-specified exploratory analysis using nuclear magnetic resonance (NMR) spectroscopy. LIVALO showed significantly greater reductions in total ...

and more »

New Data Showed LIVALO® (pitavastatin) Met Primary Endpoint of LDL-C Reduction ... - DigitalJournal.com (press release)
More...
Reply With Quote

Did you find this post helpful? Yes | No